HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Blood brain barrier permeability and therapeutic time window of Ginkgolide B in ischemia-reperfusion injury.

Abstract
The goal of this study was to estimate the blood brain barrier (BBB) permeability of Ginkgolide B in normal condition and models of ischemia both in vivo and in vitro. A sensitive LC-MS/MS analytical method was developed to determinate accurately the concentration of Ginkgolide B in cell, plasma and brain tissue. The injured rat brain microvessel endothelial cells (RBMECs) induced by Na(2)S(2)O(4) served as a hypoxia/reoxygenation model in vitro. Intracellular concentration of Ginkgolide B increased in injured cells in a concentration-dependent manner. As a model of in vivo-ischemia/reperfusion, we performed middle cerebral artery occlusion (MCAO) in rats. Concentration of Ginkgolide B in the brain tissues showed higher in cerebral ischemia-reperfused animals than that in normal rats. To evaluate potential clinical effect of Ginkgolide B, we determined therapeutic time window in MCAO rats. Up to i.v. administration at 2h after reperfusion of rats, Ginkgolide B could decrease infarction volume and brain edema, exerting significant protective effect in cerebral ischemia injury. In conclusion, Ginkgolide B could pass through BBB, especially after ischemia-reperfusion injury of brain, and might be therapeutically effective for ischemia/reperfusion injury of human brain.
AuthorsWeirong Fang, Yan Deng, Yunman Li, Erxin Shang, Fang Fang, Peng Lv, Li Bai, Yan Qi, Fang Yan, Lishun Mao
JournalEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (Eur J Pharm Sci) Vol. 39 Issue 1-3 Pg. 8-14 (Jan 31 2010) ISSN: 1879-0720 [Electronic] Netherlands
PMID19833202 (Publication Type: Journal Article)
CopyrightCopyright 2009 Elsevier B.V. All rights reserved.
Chemical References
  • Ginkgolides
  • Lactones
  • Dithionite
  • ginkgolide B
Topics
  • Animals
  • Blood-Brain Barrier (metabolism)
  • Brain (drug effects, pathology)
  • Brain Edema (drug therapy)
  • Cells, Cultured
  • Disease Models, Animal
  • Dithionite
  • Endothelial Cells (metabolism)
  • Ginkgolides (pharmacokinetics, therapeutic use)
  • Infarction, Middle Cerebral Artery (drug therapy)
  • Lactones (pharmacokinetics, therapeutic use)
  • Male
  • Permeability
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (chemically induced, metabolism, prevention & control)
  • Time Factors
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: